302 related articles for article (PubMed ID: 12880)
1. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
[TBL] [Abstract][Full Text] [Related]
3. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
Mehta J; Feldman RL; Marx JD; Kelly GA
Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of long-term oral labetalol.
Edwards RC; Raftery EB
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
[TBL] [Abstract][Full Text] [Related]
5. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
6. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
Lammintausta R; Koulu M; Allonen H
Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
[TBL] [Abstract][Full Text] [Related]
7. A review of the haemodynamic effects of labetalol in man.
Cohn JN; Mehta J; Francis GS
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):19S-26S. PubMed ID: 7093099
[TBL] [Abstract][Full Text] [Related]
8. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
[No Abstract] [Full Text] [Related]
9. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
Frishman WH; Strom JA; Kirschner M; Poland M; Klein N; Halprin S; LeJemtel TH; Kram M; Sonnenblick EH
Am J Cardiol; 1981 Nov; 48(5):917-28. PubMed ID: 6118060
[No Abstract] [Full Text] [Related]
10. The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.
Drew GM; Hilditch A; Levy GP
Clin Exp Hypertens (1978); 1979; 1(5):597-611. PubMed ID: 42517
[TBL] [Abstract][Full Text] [Related]
11. Alpha-adrenoceptor blockade by labetalol during long-term dosing.
Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F
Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864
[TBL] [Abstract][Full Text] [Related]
12. [Changes in rest and exercise hemodynamics during long term therapy with a combination alpha and beta blocker in essential hypertension].
Koch G
Verh Dtsch Ges Kreislaufforsch; 1977; 43():219-20. PubMed ID: 349925
[No Abstract] [Full Text] [Related]
13. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effect of labetalol, a new alpha- and beta-adrenergic blocking agent.
Hansson L; Hänel B
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):195-8. PubMed ID: 12115
[TBL] [Abstract][Full Text] [Related]
15. Effects of labetalol on systemic and pulmonary haemodynamics at rest and during exercise in hypertensive patients.
Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
Clin Sci Mol Med Suppl; 1978 Dec; 4():279s-281s. PubMed ID: 282068
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of intravenous labetalol in essential hypertension.
Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
[TBL] [Abstract][Full Text] [Related]
18. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
Sanders GL; Murray A; Rawlins MD
Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of combined alpha-beta-blockade. I.
Louis WJ; McNeil JJ; Drummer OH
Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
[TBL] [Abstract][Full Text] [Related]
20. Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress test responses.
Prida XE; Hill JA; Feldman RL
Am J Cardiol; 1987 May; 59(12):1084-8. PubMed ID: 2883869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
